AbbVie (ABBV) ended the recent trading session at $201.64, demonstrating a -1.73% swing from the preceding day's closing price. This change was narrower than the S&P 500's daily loss of 4.84%. On ...

AbbVie has been actively advancing its oncology portfolio with recent presentations at the AACR Annual Meeting, showcasing developments like ABBV-969 and ABBV-514, both highlighting innovation in ...

AbbVie (ABBV) closed the most recent trading day at $213.85, moving -0.29% from the previous trading session. The stock's performance was ahead of the S&P 500's daily loss of 1.07%. At the same ...

Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our Multi-Factor Investor model based on the published strategy of ...

Deep-pocketed investors have adopted a bullish approach towards AbbVie ABBV, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this ...

My last analysis on AbbVie Inc. (NYSE:ABBV) stock was published more than a month ago. More specifically, that article, titled “AbbVie Vs. Johnson & Johnson: Graham Would Prefer The Consumer ...

Investors with a lot of money to spend have taken a bearish stance on AbbVie ABBV. And retail traders should know. We noticed this today when the trades showed up on publicly available options ...

Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model based on the published strategy of ...

In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against the other best pharma stocks to buy according to hedge funds. The US pharmaceutical sector is ...